Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences, Beijing, China.
Mol Cell Biol. 2013 May;33(10):1956-64. doi: 10.1128/MCB.01580-12. Epub 2013 Mar 4.
Hepatic scavenger receptor class B type I (SR-BI) plays an important role in selective high-density lipoprotein cholesterol (HDL-C) uptake, which is a pivotal step of reverse cholesterol transport. In this study, the potential involvement of microRNAs (miRNAs) in posttranscriptional regulation of hepatic SR-BI and selective HDL-C uptake was investigated. The level of SR-BI expression was repressed by miRNA 185 (miR-185), miR-96, and miR-223, while the uptake of 1,1'-dioctadecyl-3,3,3',3'-tetramethylindocarbocyanine perchlorate (DiI)-HDL was decreased by 31.9% (P < 0.001), 23.9% (P < 0.05), and 15.4% (P < 0.05), respectively, in HepG2 cells. The inhibition of these miRNAs by their anti-miRNAs had opposite effects in these hepatic cells. The critical effect of miR-185 was further validated by the loss of regulation in constructs with mutated miR-185 target sites. In addition, these miRNAs directly targeted the 3' untranslated region (UTR) of SR-BI with a coordinated effect. Interestingly, the decrease of miR-96 and miR-185 coincided with the increase of SR-BI in the livers of ApoE KO mice on a high-fat diet. These data suggest that miR-185, miR-96, and miR-223 may repress selective HDL-C uptake through the inhibition of SR-BI in human hepatic cells, implying a novel mode of regulation of hepatic SR-BI and an important role of miRNAs in modulating cholesterol metabolism.
肝 X 受体 B 型 I 类(SR-BI)在选择性高密度脂蛋白胆固醇(HDL-C)摄取中发挥重要作用,这是胆固醇逆转运的关键步骤。在本研究中,研究了 microRNAs(miRNAs)在后转录水平对肝 SR-BI 和选择性 HDL-C 摄取的调节作用。miR-185(miR-185)、miR-96 和 miR-223 抑制 SR-BI 表达水平,而 1,1'-二辛基-3,3,3',3'-四甲基吲哚碳菁高氯酸盐(DiI)-HDL 的摄取分别减少 31.9%(P < 0.001)、23.9%(P < 0.05)和 15.4%(P < 0.05)。在 HepG2 细胞中,这些 miRNA 的抗 miRNA 抑制作用具有相反的效果。在构建具有突变 miR-185 靶位点的构建体中,miR-185 的抑制作用失去了调控作用,进一步验证了其关键作用。此外,这些 miRNA 具有协同作用,直接靶向 SR-BI 的 3'非翻译区(UTR)。有趣的是,在高脂肪饮食的 ApoE KO 小鼠肝脏中,miR-96 和 miR-185 的减少与 SR-BI 的增加相吻合。这些数据表明,miR-185、miR-96 和 miR-223 可能通过抑制人肝细胞中的 SR-BI 来抑制选择性 HDL-C 摄取,暗示了肝 SR-BI 调节的新方式和 miRNA 在调节胆固醇代谢中的重要作用。